TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
ALDX

Aldeyra Therapeutics, Inc.

Healthcare · Biotechnology

1.40$ -0.7% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Balance Sheet

Aldeyra Therapeutics, Inc. (ALDX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 72 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ALDX
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
8.8 28 25 44 95 76 83 233 181 148 105 72
8.8 28 25 44 95 75 83 233 181 148 104 72
8.5 15 12 20 47 44 78 230 144 143 55 70
8.5 28 25 43 94 73 78 230 174 143 101 70
18 44 28 25 0.0 3.2
0.0 0.0 0.0 0.0 -28 -20 -125 -3.2
0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.0
0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0
2.5 3.3 3.5 4.6 8.5 27 24 27 30 29 34 28
1.3 2.1 2.3 3.4 8.5 13 12 12 15 22 19 28
0.1 0.1 0.1 0.1 0.2 3.9 0.2 1.2 15 0.3 16
0.3 0.9 0.3 1.0 3.1 0.8 0.4 1.0 0.1 1.3 0.2 0.2
1.2 1.2 1.2 1.2 15 11 16 15 15
6.3 25 22 40 87 48 60 206 151 120 71 44
-47 -59 -77 -100 -139 -199 -237 -295 -357 -394 -450 -484
3.9 8.6 11 16 22 27 34 54 58 59 59 60

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?